ACADIA Pharmaceuticals (ACAD) had the highest return in November 2012 by a mid-cap US stock, returning 121.3%.
| ASSET | MONTH | % RETURN |
|---|---|---|
ACADIA Pharmaceuticals (ACAD) | November 2012 | 121.28% |
Abercrombie & Fitch (ANF) | November 2012 | 49.93% |
BlackBerry (BB) | November 2012 | 43.92% |
Sarepta Therapeutics (SRPT) | November 2012 | 35.72% |
JOYY (JOYY) | November 2012 | 34.95% |
Vipshop (VIPS) | November 2012 | 34.05% |
Sharplink Gaming (SBET) | November 2012 | 30.83% |
Ligand Pharmaceuticals (LGND) | November 2012 | 27.37% |
Repligen (RGEN) | November 2012 | 26.47% |
Penn National Gaming (PENN) | November 2012 | 26.11% |
Tutor Perini (TPC) | November 2012 | 26.08% |
Pilgrims Pride (PPC) | November 2012 | 25.7% |
Viavi Solutions (VIAV) | November 2012 | 24.8% |
DXC Technology (DXC) | November 2012 | 24.66% |
Callaway Golf (MODG) | November 2012 | 24.1% |
CVR Energy (CVI) | November 2012 | 24.09% |
Addus HomeCare (ADUS) | November 2012 | 23.27% |
Prestige Brand (PBH) | November 2012 | 22.94% |
Nelnet (NNI) | November 2012 | 21.81% |
Flowers Foods (FLO) | November 2012 | 20.15% |
New Oriental Education & Technology (EDU) | November 2012 | 19.57% |
Federal Agricultural Mortgage (AGM) | November 2012 | 19.31% |
HF Sinclair (DINO) | November 2012 | 19.3% |
FTI Consulting (FCN) | November 2012 | 19.25% |
Bruker (BRKR) | November 2012 | 19.09% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.
